ASO Author Reflections: Sentinel Node Navigated Surgery as a New Treatment Strategy for High-Risk T1 Esophageal Adenocarcinoma.
作者信息
Frederiks Charlotte N, Weusten Bas L A M
机构信息
Department of Gastroenterology and Hepatology, St. Antonius Hospital, Nieuwegein, The Netherlands.
Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
出版信息
Ann Surg Oncol. 2023 Jul;30(7):4012-4013. doi: 10.1245/s10434-023-13382-x. Epub 2023 Apr 4.
Abstract
摘要
相似文献
1
ASO Author Reflections: Sentinel Node Navigated Surgery as a New Treatment Strategy for High-Risk T1 Esophageal Adenocarcinoma.
Ann Surg Oncol. 2023 Jul;30(7):4012-4013. doi: 10.1245/s10434-023-13382-x. Epub 2023 Apr 4.
2
ASO Author Reflections: Lymph Node Assessment with Indocyanine Green Fluorescence in Esophageal Cancer Surgery.
Ann Surg Oncol. 2021 Sep;28(9):4878-4879. doi: 10.1245/s10434-021-09634-3. Epub 2021 Jan 29.
3
Pilot-study on the feasibility of sentinel node navigation surgery in combination with thoracolaparoscopic lymphadenectomy without esophagectomy in early esophageal adenocarcinoma patients.
Dis Esophagus. 2017 Nov 1;30(11):1-8. doi: 10.1093/dote/dox097.
4
ASO Author Reflections: The Clinical Relevance of Sentinel Nodes in Minor Lymph Node Fields Such as the Triangular Intermuscular Space in Patients with Melanoma.
Ann Surg Oncol. 2023 Sep;30(9):5770-5771. doi: 10.1245/s10434-023-13443-1. Epub 2023 May 3.
5
ASO Author Reflections: Standardizing Pathology Examination of Sentinel Lymph Nodes in Invasive Lobular Carcinoma: Less Is More.
Ann Surg Oncol. 2022 Oct;29(10):6466-6467. doi: 10.1245/s10434-022-12330-5. Epub 2022 Aug 5.
6
ASO Author Reflections: A Perspective on Nonsentinel Axillary Lymph Node Status in Sentinel Lymph Node-Positive Early Breast Cancer After Primary Systemic Therapy and ALND-Predict.
Ann Surg Oncol. 2023 Sep;30(9):5705-5706. doi: 10.1245/s10434-023-13297-7. Epub 2023 Feb 23.
7
ASO Author Reflections: Positive Sentinel Lymph Node in Breast Cancer Surgery.
Ann Surg Oncol. 2022 Feb;29(2):1096-1097. doi: 10.1245/s10434-021-10836-y. Epub 2021 Sep 24.
8
ASO Author Reflections: Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer: Is It Oncologically Safe?
Ann Surg Oncol. 2020 Dec;27(Suppl 3):707-708. doi: 10.1245/s10434-020-08954-0. Epub 2020 Jul 31.
9
ASO Author Reflections: Refining Risk Assessment in Node-Positive Breast Cancer Patients Eligible for Sentinel Lymph Node Biopsy Alone.
Ann Surg Oncol. 2020 Oct;27(10):3593-3594. doi: 10.1245/s10434-020-08634-z. Epub 2020 May 21.
10
ASO Author Reflections: Sentinel Lymph Node Removal After Neoadjuvant Chemotherapy in Clinically Node-Negative Patients Can Stop After Removal of Three Lymph Nodes.
Ann Surg Oncol. 2020 Dec;27(Suppl 3):848-849. doi: 10.1245/s10434-020-08874-z. Epub 2020 Jul 21.
引用本文的文献
1
Sentinel Node Biopsy in High-Risk pT1 Esophageal Cancer: A Long-Awaited Study.
Ann Surg Oncol. 2023 Jul;30(7):3889-3891. doi: 10.1245/s10434-023-13514-3. Epub 2023 Apr 19.
本文引用的文献
1
Analysis of metastases rates during follow-up after endoscopic resection of early "high-risk" esophageal adenocarcinoma.
Gastrointest Endosc. 2022 Aug;96(2):237-247.e3. doi: 10.1016/j.gie.2022.03.005. Epub 2022 Mar 12.
2
Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green.
Surg Endosc. 2022 Apr;36(4):2671-2679. doi: 10.1007/s00464-021-08551-6. Epub 2021 May 27.
3
Reporting National Outcomes After Esophagectomy and Gastrectomy According to the Esophageal Complications Consensus Group (ECCG).
Ann Surg. 2020 Jun;271(6):1095-1101. doi: 10.1097/SLA.0000000000003210.
4
Early-stage adenocarcinoma of the esophagus with mid to deep submucosal invasion (pT1b sm2-3): the frequency of lymph-node metastasis depends on macroscopic and histological risk patterns.
Dis Esophagus. 2017 Feb 1;30(3):1-11. doi: 10.1111/dote.12462.
Zotero 插件